e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Diagnostic methods in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative evaluation of commercially available nucleic acid amplification tests in the diagnosis of smear-negative tuberculosis
S. Morita, D. Hashimoto, K. Tsukamoto, R. Tamura, T. Suda, K. Chida, H. Nakamura (Surugadai, Fujieda, Handayama, Japan)
Source:
Annual Congress 2002 - Diagnostic methods in tuberculosis
Session:
Diagnostic methods in tuberculosis
Session type:
Poster Discussion
Number:
3592
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Morita, D. Hashimoto, K. Tsukamoto, R. Tamura, T. Suda, K. Chida, H. Nakamura (Surugadai, Fujieda, Handayama, Japan). Comparative evaluation of commercially available nucleic acid amplification tests in the diagnosis of smear-negative tuberculosis. Eur Respir J 2002; 20: Suppl. 38, 3592
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Role of specialists in the application of a nucleic acid amplification test for the rapid diagnosis of pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 167s
Year: 2002
Sensitivity and specificity of nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis: a meta-analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 161s
Year: 2003
Comparison of
Mycobacterium tuberculosis
drug susceptibility tests by nucleic acid amplification and classic technique
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
Prevalence of positivity of CBNAAT(cartridge based nucleic acid amplification test) in extra-pulmonary tuberculosis.
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018
Nucleic acid amplification tests (naat): diagnostic value for pulmonary tuberculosis
Source: Annual Congress 2009 - Diagnostic advances in tuberculosis
Year: 2009
The role of bronchoscopy and nucleic acid amplification test in pulmonary tuberculosis diagnosis
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Source: Eur Respir J 2012; 40: 442-447
Year: 2012
Nucleic acid amplification improves the accuracy of sputum induction in the rapid diagnosis of pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 419s
Year: 2005
Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children
Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents
Year: 2008
Comparison of molecular and immunological methods for a rapid diagnosis of smear-negative tuberculosis
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Evaluation of DestiNA ‘spin-tube’ technology – a novel test for the diagnosis of tuberculosis and mycobacteriosis
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020
Novel sequence-based assay for detection of pyrazinamide-resistant
mycobacterium tuberculosis
in clinical specimens from patients with pulmonary tuberculosis in Russia
Source: Annual Congress 2011 - Tuberculosis: from bench to bedside
Year: 2011
Comparison of rapid in-house methods for drug susceptibility testing of
mycobacterium tuberculosis
with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
The quantiferon testing and the diagnosis of tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008
Performance of five serological tests using different antigens in rapid diagnosis of tuberculosis
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Rapid detection of tuberculosis at the point-of-care
Source: Annual Congress 2013 –Point-of-care tests for respiratory infectious diseases
Year: 2013
Semiquantitation of tuberculosis bacilli (MTB) and nontuberculous mycobacteria (NTM) in sputum by a new nucleic acid amplification test (NAAT)
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept